Correlation Between NYSE Composite and CERo Therapeutics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and CERo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and CERo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and CERo Therapeutics Holdings, you can compare the effects of market volatilities on NYSE Composite and CERo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of CERo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and CERo Therapeutics.
Diversification Opportunities for NYSE Composite and CERo Therapeutics
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between NYSE and CERo is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and CERo Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CERo Therapeutics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with CERo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CERo Therapeutics has no effect on the direction of NYSE Composite i.e., NYSE Composite and CERo Therapeutics go up and down completely randomly.
Pair Corralation between NYSE Composite and CERo Therapeutics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 68.02 times less return on investment than CERo Therapeutics. But when comparing it to its historical volatility, NYSE Composite is 66.93 times less risky than CERo Therapeutics. It trades about 0.29 of its potential returns per unit of risk. CERo Therapeutics Holdings is currently generating about 0.29 of returns per unit of risk over similar time horizon. If you would invest 0.54 in CERo Therapeutics Holdings on August 31, 2024 and sell it today you would earn a total of 1.41 from holding CERo Therapeutics Holdings or generate 261.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
NYSE Composite vs. CERo Therapeutics Holdings
Performance |
| Timeline |
NYSE Composite and CERo Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
CERo Therapeutics Holdings
Pair trading matchups for CERo Therapeutics
Pair Trading with NYSE Composite and CERo Therapeutics
The main advantage of trading using opposite NYSE Composite and CERo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, CERo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CERo Therapeutics will offset losses from the drop in CERo Therapeutics' long position.| NYSE Composite vs. Nextplat Corp | NYSE Composite vs. Qualys Inc | NYSE Composite vs. Cadence Design Systems | NYSE Composite vs. Asure Software |
| CERo Therapeutics vs. Viracta Therapeutics | CERo Therapeutics vs. Dogwood Therapeutics, | CERo Therapeutics vs. Viking Therapeutics | CERo Therapeutics vs. Dyadic International |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |